Table 5

Significant clinical morbidity for non-musculoskeletal disorders by case and control groups

Morbidity (Read code)OA cases No (%)Non-OA controls No (%)OR* (99 % CI)
*Adjusted for age, sex, and social class; non-OA group is reference group, all statistically significant at 1% level; †results (not shown) which were significant at 1% level when adjusted for age, sex, social class, and categories of morbidity counts as defined by number of specific disease groups each subject had consulted for in the study year; non-OA group is the reference group.
Obesity and other disorders (C38)317 (2.8)148 (1.3)2.25 (1.73 to 2.92)†
Gastritis and duodenitis (J15)214 (1.9)113 (1.0)1.98 (1.46 to 2.68)†
Phlebitis and thrombophlebitis (G80)161 (1.4)93 (0.8)1.80 (1.28 to 2.52)†
Diaphragmatic (hiatus) hernia (J34)167 (1.5)95 (0.8)1.80 (1.29 to 2.51)†
Ischaemic heart disease (G3)97 (0.9)58 (0.5)1.73 (1.13 to 2.66)†
Cellulitis and abscess of finger or toe (M02)124 (1.1)76 (0.6)1.67 (1.14 to 2.43)†
Diverticula of intestine (J51)179 (1.6)114 (1.0)1.63 (1.20 to 2.23)†
Other procedure complication (SP2)100 (0.9)66 (0.6)1.63 (1.08 to 2.45)
Lachrymal system disorders (F4F)174 (1.5)112 (1.0)1.61 (1.18 to 2.21)†
Disorders of stomach function (J16)631 (5.5)407 (3.5)1.61 (1.36 to 1.90)†
Gout (C34)196 (1.7)134 (1.1)1.53 (1.14 to 2.05)†
Acute respiratory infections (H0.)190 (1.7)126 (1.1)1.53 (1.13 to 2.06)†
Chronic pharyngitis and nasopharyngitis (H12)224 (2.0)153 (1.3)1.51 (1.15 to 1.99)†
Chronic skin ulcer (M27)118 (1.0)81 (0.7)1.49 (1.02 to 2.17)
Urinary system symptoms (R08)234 (2.1)163 (1.4)1.48 (1.13 to 1.93)
Erythematosquamous dermatosis (M10)139 (1.2)97 (0.8)1.47 (1.04 to 2.08)
Depressive disorder (E2B)314 (2.8)223 (1.9)1.45 (1.15 to 1.82)
Varicose veins of the legs (G83)423 (3.7)307 (2.6)1.42 (1.17 to 1.73)†
Dermatitis or other eczema (M12)327 (2.9)239 (2.0)1.42 (1.14 to 1.78)†
Iron deficiency anaemia (D00)186 (1.6)134 (1.1)1.41 (1.05 to 1.89)
Fall on same level (TC5)368 (3.2)267 (2.3)1.40 (1.13 to 1.73)
Functional gastrointestinal disorders (J52)600 (5.3)448 (3.8)1.38 (1.17 to 1.63)
Symptoms affecting skin and other tissues (R02)524 (4.6)397 (3.4)1.37 (1.15 to 1.64)†
Angina pectoris (G33)654 (5.7)499 (4.2)1.36 (1.16 to 1.59)†
Digestive system symptoms (R07)243 (2.1)183 (1.6)1.35 (1.04 to 1.74)
Adverse effects (SN5)596 (5.2)459 (3.9)1.35 (1.14 to 1.59)
Erythematous conditions (M15)213 (1.9)164 (1.4)1.33 (1.01 to 1.74)
Peripheral vascular disease (G73)216 (1.9)168 (1.4)1.32 (1.01 to 1.72)
Diseases of oesophagus (J10)396 (3.5)309 (2.6)1.32 (1.08 to 1.61)
Injury – accidental, by other means (TN8)1516 (13.3)1228 (10.4)1.32 (1.18 to1.46)
Other urethral and urinary tract disorders (K19)716 (6.3)563 (4.8)1.31 (1.13 to 1.52)
Other cellulitis and abscess (M03)297 (2.6)233 (2.0)1.31 (1.04 to 1.64)
Candidiasis (AB2)259 (2.3)206 (1.7)1.30 (1.02 to 1.66)
Heart failure (G58)542 (4.8)432 (3.7)1.28 (1.07 to 1.52)
Head and neck symptoms (R04)308 (2.7)246 (2.1)1.28 (1.02 to 1.60)
Disorders of conjunctiva (F4C)667 (5.9)559 (4.7)1.24 (1.06 to 1.44)
General symptoms (R00)858 (7.5)713 (6.1)1.24 (1.09 to 1.42)
Other abdominal and pelvic symptoms (R09)440 (3.9)369 (3.1)1.23 (1.02 to 1.48)
Ill-defined intestinal tract infections (A08)391 (3.4)329 (2.8)1.22 (1.00 to 1.48)
Respiratory system and chest symptoms (R06)710 (6.2)604 (5.1)1.22 (1.05 to 1.41)
Other acute upper respiratory infections (H05)574 (5.0)487 (4.1)1.21 (1.03 to 1.43)
Neurotic disorders (E20)810 (7.1)706 (6.0)1.18 (1.03 to 1.36)
Acute bronchitis and bronchiolitis (H06)1705 (15.0)1565 (13.3)1.13 (1.02 to 1.24)
Senile or pre-senile organic psychosis (E00)62 (0.5)94 (0.8)0.65 (0.43 to 1.00)†